Mary Jane Salinas

Mary Jane Salinas, PharmD, currently serves as the Head of US Scientific Communications and Evidence Generation at ITF Therapeutics LLC since July 2024. Previously, Mary Jane held the position of Director, Head of Publications at Intercept Pharmaceuticals from September 2022 to July 2024 and served as the Head of Scientific Communications at Taysha Gene Therapies between June 2021 and October 2022. Prior roles include Associate Director, US Medical Communications at EMD Serono, Inc., and Manager of Medical Information at Teva Pharmaceuticals. Mary Jane has extensive experience in medical communications strategy, publication planning, and scientific communications across various therapeutic areas, including neurology and rare diseases. A Doctor of Pharmacy, Mary Jane earned the degree from the University of Missouri-Kansas City.